» Articles » PMID: 20003372

Incidence and Classification of Pediatric Diffuse Parenchymal Lung Diseases in Germany

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2009 Dec 17
PMID 20003372
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diffuse parenchymal lung diseases (DPLD) in children represent a rare and heterogeneous group of chronic pulmonary disorders. Despite substantial advances in enetics and pathomechanisms, these often lethal diseases are still under-diagnosed. This is due to the fact that (i) the incidence is low, and (ii) clinical presentation, (iii) disease classification and (iv) specific treatment options are largely unknown.

Methods: Here we systematically assessed the incidence, the presentation, the diagnostic yield and treatments of pediatric DPLD in Germany, using the Surveillance Unit for Rare Paediatric Disorders (ESPED).

Results: The incidence of DPLD was 1.32 new cases per 1 million of children per year. The majority of these children were diagnosed within the first year of life. Overall survival was 87%. Using centralized data entry and stratification tools, the patients were categorized into an advanced classification system based on diagnostic algorithms, including clinical presentations, genetics and/or histology. Combining molecular and clinical information, this survey provides an etiological overview and specific diagnostic recommendations for children with DPLD.

Conclusions: Standardized surveys and systematic classifications are valuable tools for the clinical handling of children with DPLD and aim to improve the disease understanding and the prognosis of these rare detrimental lung diseases.

Citing Articles

c.838C>T (p.Arg280Cys, R280C) and c.697C>T (p.Gln233Ter, Q233X, Q233*) as Causative Variants for RDS: A Family Case Study and Literature Review.

Ognean M, Anciuc-Crauciuc M, Galis R, Stepan A, Stepan M, Banescu C Biomedicines. 2024; 12(10).

PMID: 39457702 PMC: 11505159. DOI: 10.3390/biomedicines12102390.


Engraftment of wild-type alveolar type II epithelial cells in surfactant protein C deficient mice.

Predella C, Lapsley L, Ni K, Murray J, Liu H, Motelow J Res Sq. 2024; .

PMID: 39315275 PMC: 11419168. DOI: 10.21203/rs.3.rs-4673915/v1.


The Clinical Approach to Interstitial Lung Disease in Childhood: A Narrative Review Article.

Drobnakova S, Vargova V, Barkai L Children (Basel). 2024; 11(8).

PMID: 39201839 PMC: 11352674. DOI: 10.3390/children11080904.


Pulmonary fibrosis may begin in infancy: from childhood to adult interstitial lung disease.

Griese M, Kurland G, Cidon M, Deterding R, Epaud R, Nathan N Thorax. 2024; 79(12):1162-1172.

PMID: 39153860 PMC: 11671978. DOI: 10.1136/thorax-2024-221772.


Childhood interstitial lung diseases: current understanding of the classification and imaging findings.

Tsujioka Y, Nishimura G, Nishi E, Kono T, Nozaki T, Hashimoto M Jpn J Radiol. 2024; 42(9):937-952.

PMID: 39012450 PMC: 11364587. DOI: 10.1007/s11604-024-01603-6.


References
1.
Wert S, Whitsett J, Nogee L . Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol. 2009; 12(4):253-74. PMC: 2987676. DOI: 10.2350/09-01-0586.1. View

2.
Hallman M, Haataja R . Genetic basis of respiratory distress syndrome. Front Biosci. 2006; 12:2670-82. DOI: 10.2741/2263. View

3.
Clement A, Eber E . Interstitial lung diseases in infants and children. Eur Respir J. 2008; 31(3):658-66. DOI: 10.1183/09031936.00004707. View

4.
Dinwiddie R, Sharief N, Crawford O . Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol. 2002; 34(1):23-9. DOI: 10.1002/ppul.10125. View

5.
Deutsch G, Young L, Deterding R, Fan L, Dell S, Bean J . Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 2007; 176(11):1120-8. PMC: 2176101. DOI: 10.1164/rccm.200703-393OC. View